Clinical Trial Update: Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing empagliflozin to non-SGLT2 oral medications for blood pressure in people with type 2 diabetes and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Dr. Zarmina Younes | Conditions: Type 2 Diabetes Mellitus, Hypertension | Phase 4 | Status: COMPLETED